Publication:
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD

dc.contributor.authorMatur, Zeliha
dc.contributor.institutionauthorMATUR, ZELİHA
dc.date.accessioned2022-01-13T21:00:34Z
dc.date.available2022-01-13T21:00:34Z
dc.date.issued2021-06-01T00:00:00Z
dc.identifier.citationMatur Z., -Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD-, Annals Of Neurology, cilt.89, sa.6, ss.1088-1098, 2021
dc.identifier.doi10.1002/ana.26049
dc.identifier.pubmed33586143
dc.identifier.scopus8510182826
dc.identifier.urihttp://hdl.handle.net/20.500.12645/30187
dc.identifier.wosWOS:000622422800001
dc.titleLong-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD
dc.typeArticle
dspace.entity.typePublication
local.avesis.idfc3480e3-b308-4163-b6a9-91cf2d9af7e1
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1
relation.isAuthorOfPublication3c69fce6-5ba0-4838-9215-eae7a7125446
relation.isAuthorOfPublication.latestForDiscovery3c69fce6-5ba0-4838-9215-eae7a7125446

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Annals of Neurology - 2021 - Wingerchuk - Long‐Term Safety and Efficacy of Eculizumab in Aquaporin‐4 IgG‐Positive NMOSD.pdf
Size:
968.17 KB
Format:
Adobe Portable Document Format

Collections